MANGALAM DRUGS AND ORGANICS
Back to Cashflow Statement
|
MANGALAM DRUGS AND ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹5.70 Cr | ₹-17 Cr | ₹2.98 Cr | ₹2.70 Cr | ₹-23 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANGALAM DRUGS AND ORGANICS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹5.70 Cr |
Mar2023 | ₹-17 Cr |
Mar2022 | ₹2.98 Cr |
Mar2021 | ₹2.70 Cr |
Mar2020 | ₹-23 Cr |
How is Cash Flow from Financing Activities of MANGALAM DRUGS AND ORGANICS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹5.70 Cr | Positive | |
Mar2023 | ₹-17 Cr | Negative | |
Mar2022 | ₹2.98 Cr | 10.42 | |
Mar2021 | ₹2.70 Cr | Positive | |
Mar2020 | ₹-23 Cr | - |
Compare Cash Flow from Financing Activities of peers of MANGALAM DRUGS AND ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM DRUGS AND ORGANICS | ₹161.1 Cr | -11% | -13.4% | 3.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
MANGALAM DRUGS AND ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM DRUGS AND ORGANICS | -11% |
-13.4% |
3.6% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses